GW 9508

CAS No. 885101-89-3

GW 9508( GW9508 | GW-9508 | GW 9508 )

Catalog No. M16407 CAS No. 885101-89-3

GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 28 In Stock
25MG 46 In Stock
50MG 73 In Stock
100MG 133 In Stock
200MG 197 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GW 9508
  • Note
    Research use only, not for human use.
  • Brief Description
    GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32.
  • Description
    GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32, 100-fold selective against GPR120, stimulates insulin secretion in a glucose-sensitive manner.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GW9508 | GW-9508 | GW 9508
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    GPR120| GPR40(FFA1)
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    885101-89-3
  • Formula Weight
    347.41
  • Molecular Formula
    C22H21NO3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 69 mg/mL (198.61 mM); DMSO: 69 mg/mL (198.61 mM)
  • SMILES
    O=C(O)CCC1=CC=C(NCC2=CC=CC(OC3=CC=CC=C3)=C2)C=C1
  • Chemical Name
    3-(4-((3-phenoxybenzyl)amino)phenyl)propanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Briscoe CP, et al. Br J Pharmacol, 2006, 148(5), 619-628.
molnova catalog
related products
  • CRTh2 antagonist 1

    CRTh2 antagonist 1 is a CRTh2 antagonist [IC50: 89 nM].

  • LY2881835

    LY2881835 is a potent and selective GPR40 agonist.

  • WAY-298630

    (2-{[2-(2-fluorophenoxy)ethyl]sulfanyl}-1H-benzimidazol-1-yl)acetic acid is a prostaglandin-like CRTH2 antagonist with an IC50 < 10 μM, which can be used in studies of rhinitis, COPD, rheumatoid arthritis, eczema and conjunctivitis.